A phase 1 trial of imatinib, bevacizumab, and metronomic cyclophosphamide in advanced colorectal cancer
about
Combinations of vascular endothelial growth factor pathway inhibitors with metronomic chemotherapy: Rational and current statusMetronomic oral cyclosphosphamide as third-line systemic treatment or beyond in patients with inoperable locoregionally advanced recurrent or metastatic nasopharyngeal carcinoma.Addition of rapamycin and hydroxychloroquine to metronomic chemotherapy as a second line treatment results in high salvage rates for refractory metastatic solid tumors: a pilot safety and effectiveness analysis in a small patient cohortThe neuroleptic drug pimozide inhibits stem-like cell maintenance and tumorigenicity in hepatocellular carcinoma.Combined therapy with thrombospondin-1 type I repeats (3TSR) and chemotherapy induces regression and significantly improves survival in a preclinical model of advanced stage epithelial ovarian cancer.Analysis of the lipidome of xenografts using MALDI-IMS and UHPLC-ESI-QTOF.From palliative to curative treatment - stage IV mucinous adenocarcinoma, successfully treated with metronomic capecitabine in combination with Bevacizumab and surgery- a case report.Dual Metronomic Chemotherapy with Nab-Paclitaxel and Topotecan Has Potent Antiangiogenic Activity in Ovarian Cancer.The differential effects of metronomic gemcitabine and antiangiogenic treatment in patient-derived xenografts of pancreatic cancer: treatment effects on metabolism, vascular function, cell proliferation, and tumor growth.Metronomic Chemotherapy: Seems Prowess to Battle against Cancer in Current ScenarioMetronomics: towards personalized chemotherapy?A systematic literature analysis of correlative studies in low-dose metronomic chemotherapy trials.An overview of experimental and investigational multikinase inhibitors for the treatment of metastatic colorectal cancer.Imatinib and its combination with 2,5-dimethyl-celecoxibinduces apoptosis of human HT-29 colorectal cancer cells.Inclusion of targeted therapies in the standard of care for metastatic colorectal cancer patients in a German cancer center: the more the better?!Trial Watch: Chemotherapy with immunogenic cell death inducers.Successful Second-Line Metronomic Temozolomide in Metastatic Paraganglioma: Case Reports and Review of the Literature.
P2860
Q27001560-CC8F5595-029C-4177-A366-75EB32BFC1CBQ30846827-821F649D-2EB2-4888-8113-9884890F1F52Q33422577-343193D9-49CD-4508-B421-04798E716631Q33566593-4362E84F-FE34-45F8-8C30-AB14E2ABB3CCQ35039333-5CE2B9F7-A0B6-4A93-A47F-9165E9882CE8Q35156348-E92E4E69-4C45-4405-8DA7-E72CF418B467Q35837505-E1254356-9610-4705-BBDE-9C0DFFE6CB9BQ36359684-AF3AB7E4-5FCF-40C5-B33E-97F458371CE7Q36761584-409E0D5A-BBA2-4ED0-9690-657B51872F05Q37543011-B5B69426-E5FF-410B-999A-C269A05406F2Q38218923-EDDCEC82-FAED-473A-BEB0-75C51EF040ABQ38249998-1F19DC88-667C-401B-9170-DD893E579E54Q38554714-3EC10EC6-4C0D-4150-885D-B6F290C8317FQ38714062-8AC24C4E-AB17-4ED6-924B-8B0F7C4A30ADQ50631598-9F917C80-FA51-447C-A961-0F11F961DDCFQ55260834-6BF378D1-738A-4F63-892D-A79B6CB64A39Q55332110-A615B633-B580-4129-B53D-9304DFB78799
P2860
A phase 1 trial of imatinib, bevacizumab, and metronomic cyclophosphamide in advanced colorectal cancer
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 10 September 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A phase 1 trial of imatinib, b ...... in advanced colorectal cancer
@en
A phase 1 trial of imatinib, b ...... in advanced colorectal cancer.
@nl
type
label
A phase 1 trial of imatinib, b ...... in advanced colorectal cancer
@en
A phase 1 trial of imatinib, b ...... in advanced colorectal cancer.
@nl
prefLabel
A phase 1 trial of imatinib, b ...... in advanced colorectal cancer
@en
A phase 1 trial of imatinib, b ...... in advanced colorectal cancer.
@nl
P2093
P2860
P921
P356
P1476
A phase 1 trial of imatinib, b ...... in advanced colorectal cancer
@en
P2093
A P Venook
E K Bergsland
P2860
P2888
P304
P356
10.1038/BJC.2013.553
P407
P50
P577
2013-09-10T00:00:00Z